Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Slamon

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|September 14, 2001
Identification of a heregulin binding site in HER3 extracellular domainE Singer, R Landgraf, T Horan, et al.
Princess Takamatsu Symposia|January 1, 1984
The comparative molecular biology of HTLV-I and HTLV-IIJ Rosenblatt, W Wachsman, K Shimotohno, et al.
Archives of Toxicology|August 3, 2001
Assessment of DNA damage in C6 glioma cells after antidepressant treatment using an alkaline comet assayN D Slamon, T H Ward, J Butler, et al.
Viral Immunology|January 1, 1992
Human T-cell leukemia virus type-I/II (HTLV-I/II) serologic testing: the importance of assaying for the full complement of viral antigensD M Aboulafia, C Bennett, H Koga, et al.
The Journal of Urology|February 1, 1995
Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissueT Strohmeyer, D Reese, M Press, et al.
Cancer Research|September 1, 1985
Human T-cell leukemia virus x geneW Wachsman, D Slamon, K Shimotohno, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1991
Correlation between retinoblastoma gene expression and differentiation in human testicular tumorsT Strohmeyer, P Reissmann, C Cordon-Cardo, et al.
Science (New York, N.Y.)|September 28, 1990
Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2R Lupu, R Colomer, G Zugmaier, et al.
AIDS Research and Human Retroviruses|October 1, 1993
Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug usersD M Aboulafia, E Feigal, K Vranzian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2010
Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cellsB C Browne, J Crown, N Venkatesan, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|September 14, 2001
Identification of a heregulin binding site in HER3 extracellular domainE Singer, R Landgraf, T Horan, et al.
Princess Takamatsu Symposia|January 1, 1984
The comparative molecular biology of HTLV-I and HTLV-IIJ Rosenblatt, W Wachsman, K Shimotohno, et al.
Archives of Toxicology|August 3, 2001
Assessment of DNA damage in C6 glioma cells after antidepressant treatment using an alkaline comet assayN D Slamon, T H Ward, J Butler, et al.
Viral Immunology|January 1, 1992
Human T-cell leukemia virus type-I/II (HTLV-I/II) serologic testing: the importance of assaying for the full complement of viral antigensD M Aboulafia, C Bennett, H Koga, et al.
The Journal of Urology|February 1, 1995
Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissueT Strohmeyer, D Reese, M Press, et al.
Cancer Research|September 1, 1985
Human T-cell leukemia virus x geneW Wachsman, D Slamon, K Shimotohno, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1991
Correlation between retinoblastoma gene expression and differentiation in human testicular tumorsT Strohmeyer, P Reissmann, C Cordon-Cardo, et al.
Science (New York, N.Y.)|September 28, 1990
Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2R Lupu, R Colomer, G Zugmaier, et al.
AIDS Research and Human Retroviruses|October 1, 1993
Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug usersD M Aboulafia, E Feigal, K Vranzian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2010
Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cellsB C Browne, J Crown, N Venkatesan, et al.
Pageof 5